Praxis Precision Medicines, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 09/30/24 | FY 06/30/24 | FY 03/31/24 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.0 | $8.6 | — | — | — |
| Operating income | -$326.2 | -$200.2 | — | — | — |
| Net income | -$303.3 | -$182.8 | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$249.1 | -$131.8 | — | — | — |
Shares outstanding 27.9M · Free float 61.3%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.